{
  "ticker": "IMU",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966029",
  "id": "02966029",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250704",
  "time": "0942",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250704/pdf/06lgk252tljsbh.pdf",
  "summary": "- **R&D Tax Refund Received**: AUD $5,872,248 (including AUD $84,990 interest).  \n- **Use of Funds**: To advance clinical development of immuno-oncology pipeline.  \n\n*No material trading or capital markets impacts identified beyond liquidity boost from refund.*",
  "usage": {
    "prompt_tokens": 883,
    "completion_tokens": 59,
    "total_tokens": 942,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-03T23:58:21.518124"
}